Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

FuturHealth vs Wisp

By GLP-1 ScorecardUpdated

FuturHealthFactor scores not reassessed.
Site position #235

Higher score

WispFactor scores not reassessed.
Site position #258

Lower score

Score comparison

FuturHealth has the higher recorded score — 65.6/100 to 64.4/100, but only just.

FuturHealth grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. FuturHealth advertises named brand-name medications at introductory-dose prices, alongside nutrition and fitness tools. Wisp is close behind and may still be the better fit — see the factor split below.

Before you choose

Before comparing the headline prices, the FuturHealth review and the Wisp review set out what each semaglutide figure in the table below covers, including whether the medication is a brand-name product billed by a pharmacy. Brand-name and compounded prices are different products, so set like against like before treating either one as cheaper.

If neither one fits, Care Bare Rx vs FuturHealth and GOAL.MD vs Wisp compare each of them with another graded program, and the list of alternatives to FuturHealth ranks the programs closest to FuturHealth on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

Of the sellers that pay us a commission, the Oak review covers one graded close to these two, at 63.2/100. That relationship never changes a grade, and the review lists what we could not verify.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueFuturHealth +10
60
50
Dose & formulationFuturHealth +5
81
76
Clinical oversightWisp +15
67
82
Labs & monitoringFuturHealth +8
61
53
FulfillmentWisp +4
62
66
Contract termsEven
55
55
FuturHealth · top barWisp · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricFuturHealthWisp
WeighScore65.6/10064.4/100
GradeCC
Site position#235#258
Semaglutide$198/mo (Wegovy pill intro dose)$225/mo (compounded oral)
Tirzepatide$395/mo (Zepbound KwikPen intro dose)Not disclosed
CoverageCoverage not publishedCoverage not published
Brand-name accessYesYes
Oral / sublingualYesYes
FuturHealth

Site position #235 · C

Factor scores not reassessed.

Strengths

  • Names the brand and format on its introductory price cards.
  • Publishes its subscription cancellation and refund terms.

What to consider

  • Introductory figures leave continuing and all-in charges open.
  • The membership guarantee excludes medication and most third-party charges.
Wisp

Site position #258 · C

Factor scores not reassessed.

Strengths

  • Lists a separate compounded drops offer
  • Describes monthly provider check-ins

What to consider

  • The consultation price does not establish the pharmacy bill
  • Confirm state eligibility and the cancellation cutoff for your plan

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

Commercial relationships affect this placement. The score comparison above is separate.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard